Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Schulz

Showing results (321-330 of 906) with videos related to

Pageof 91
Sort By:
Neuropharmacology|July 11, 2001
The metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) blocks fear conditioning in ratsB Schulz, M Fendt, F Gasparini, et al.
Krankenpflege (Frankfurt Am Main, Germany)|February 1, 1992
[Project paper at the Agnes Karll Institute. Parallel research project on "Structural improvement of nursing care through the installation of ward assistants"]S Bartholomeyczik, E Donath, M Krohwinkel, et al.
The Journal of Diabetic Complications|April 1, 1989
Frequency and therapy of end-stage renal disease due to diabetic nephropathy in the German Democratic RepublicE Zander, B Schulz, E Jutzi, et al.
Neuromuscular Disorders : NMD|November 7, 2016
Tubular aggregates in autoimmune Lambert-Eaton myasthenic syndromeIsabell Cordts, Fabian Funk, Jörg B Schulz, et al.
Eye (London, England)|February 1, 2023
Automated extraction of clinical measures from videos of oculofacial disorders using machine learning: feasibility, validity and reliabilityChristopher B Schulz, Holly Clarke, Sarith Makuloluwe, et al.
Translational Andrology and Urology|March 21, 2025
Prophylactic Use of Biologic Mesh in Ileal Conduit (PUBMIC trial)Nikolaos Pyrgidis, Gerald B Schulz, Christian G Stief, et al.
Journal of Neurochemistry|December 24, 2003
Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activationThomas Dehmer, Michael T Heneka, Magdalena Sastre, et al.
Journal of Neurochemistry|December 1, 1993
Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosisA C Bowling, J B Schulz, R H Brown, et al.
Experimental Neurology|April 1, 1995
Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicityJ B Schulz, D R Henshaw, R T Matthews, et al.
Cell and Tissue Research|September 2, 2004
The dopaminergic nigrostriatal system: development, physiology, diseaseOliver von Bohlen Und Halbach, Kerstin Krieglstein, Andreas Schober, et al.
Pageof 91

Showing results (321-330 of 906) with videos related to

Sort By:
Pageof 91
Neuropharmacology|July 11, 2001
The metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) blocks fear conditioning in ratsB Schulz, M Fendt, F Gasparini, et al.
Krankenpflege (Frankfurt Am Main, Germany)|February 1, 1992
[Project paper at the Agnes Karll Institute. Parallel research project on "Structural improvement of nursing care through the installation of ward assistants"]S Bartholomeyczik, E Donath, M Krohwinkel, et al.
The Journal of Diabetic Complications|April 1, 1989
Frequency and therapy of end-stage renal disease due to diabetic nephropathy in the German Democratic RepublicE Zander, B Schulz, E Jutzi, et al.
Neuromuscular Disorders : NMD|November 7, 2016
Tubular aggregates in autoimmune Lambert-Eaton myasthenic syndromeIsabell Cordts, Fabian Funk, Jörg B Schulz, et al.
Eye (London, England)|February 1, 2023
Automated extraction of clinical measures from videos of oculofacial disorders using machine learning: feasibility, validity and reliabilityChristopher B Schulz, Holly Clarke, Sarith Makuloluwe, et al.
Translational Andrology and Urology|March 21, 2025
Prophylactic Use of Biologic Mesh in Ileal Conduit (PUBMIC trial)Nikolaos Pyrgidis, Gerald B Schulz, Christian G Stief, et al.
Journal of Neurochemistry|December 24, 2003
Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activationThomas Dehmer, Michael T Heneka, Magdalena Sastre, et al.
Journal of Neurochemistry|December 1, 1993
Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosisA C Bowling, J B Schulz, R H Brown, et al.
Experimental Neurology|April 1, 1995
Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicityJ B Schulz, D R Henshaw, R T Matthews, et al.
Cell and Tissue Research|September 2, 2004
The dopaminergic nigrostriatal system: development, physiology, diseaseOliver von Bohlen Und Halbach, Kerstin Krieglstein, Andreas Schober, et al.
Pageof 91